BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

101 related articles for article (PubMed ID: 4602504)

  • 1. [5-nitro-8-oxyquinoline in the treatment of chronic pyelonephritis].
    Leńko J; Markiewicz K; Trznadel K
    Pol Tyg Lek; 1974 Jun; 29(24):1045-7. PubMed ID: 4602504
    [No Abstract]   [Full Text] [Related]  

  • 2. [5-NOC in the treatment of pyelonephritis in children].
    Vlatković G; Uhlik Z; Babić I; Votava-Sprem A
    Lijec Vjesn; 1971; 93(3):339-47. PubMed ID: 5142160
    [No Abstract]   [Full Text] [Related]  

  • 3. [Antibacterial activity of nitrooxyquinoline studied in 2 experimental models of pyelonephritis induced by Escherichia coli in rats].
    Hatala M; Hnátek J; Liska M; Konícková L; Uhlír O; Prát V
    Cas Lek Cesk; 1973; 112(23):722-5. PubMed ID: 4577401
    [No Abstract]   [Full Text] [Related]  

  • 4. [1st experiences with 5-nitro-oxyquinoline in the treatment of chronic urinary tract infection].
    Schlesinger E; Patsch R; Kraft M
    Z Urol Nephrol; 1975 Jun; 70(6):429-34. PubMed ID: 810992
    [No Abstract]   [Full Text] [Related]  

  • 5. [Ciprofloxacin and cefotaxim: pharmacokinetic and therapeutic effectiveness in E. coli pyelonephritis in rats].
    Tietgen K; Schulz E; Boness J; Marre R
    Immun Infekt; 1986 Jul; 14(4):152-5. PubMed ID: 2943665
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Treatment of Escherichia coli pyelonephritis with cephaloridine.
    Ueda Y; Matsumoto F; Saito A; Ohmori M
    Postgrad Med J; 1967 Aug; 43():Suppl 43:80-1. PubMed ID: 4861121
    [No Abstract]   [Full Text] [Related]  

  • 7. [Clinical evaluation of cephalexin monohydrate in the treatment of pyelonephritis].
    Hernandez Alvarez G; Mancera Massieu R; Exaire Murad JE
    Prensa Med Mex; 1970; ():75-82. PubMed ID: 4931122
    [No Abstract]   [Full Text] [Related]  

  • 8. [Characteristics of acute pyelonephritis that require hospital admission].
    Pascual Pérez R; Serrano Barroso R; Muñoz Pérez E; Cantero I
    Rev Clin Esp; 2010 Sep; 210(8):423-4. PubMed ID: 20673664
    [No Abstract]   [Full Text] [Related]  

  • 9. Clinical trials with oral oxamniquine (UK 4271) for the treatment of mansonian schistosomiasis.
    da Silva LC; Sette H; Chamone DA; Alquezar AS; Punskas JA; Raia S
    Rev Inst Med Trop Sao Paulo; 1974 Mar; 16(2):103-9. PubMed ID: 4845456
    [No Abstract]   [Full Text] [Related]  

  • 10. Clinical and laboratory studies on oxafuradene.
    Geddes AJ; Gray JA; Murdoch M; Wallace ET
    Antimicrob Agents Chemother (Bethesda); 1965; 5():677-8. PubMed ID: 5327526
    [No Abstract]   [Full Text] [Related]  

  • 11. [Clinical evaluation of cephalexin monohydrate in the treatment of infections of the genitourinary system].
    Aspe AJ
    Prensa Med Mex; 1970; ():45-50. PubMed ID: 4931116
    [No Abstract]   [Full Text] [Related]  

  • 12. [Management of chronic diseases and clinical judgment of cure--bacterial pyelonephritis].
    Ueda Y; Matsumoto F
    Nihon Rinsho; 1966 Dec; 24(12):2256-60. PubMed ID: 5341280
    [No Abstract]   [Full Text] [Related]  

  • 13. [Use of gamma globulin in chronic pyelonephritis].
    Kobelev AA; Ebert LIa; Korobeĭnikova EN
    Sov Med; 1980; (1):75-8. PubMed ID: 6154318
    [No Abstract]   [Full Text] [Related]  

  • 14. [Fibronectin and its significance in pyelonephritis].
    Rudenko AV; Maĭdannik VG; Drannik GN; Romanenko AM; Bavina EN; Dem'ianova TV
    Urol Nefrol (Mosk); 1993; (3):13-6. PubMed ID: 7941152
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Stimulative therapy in chronic pyelonephritis].
    Kobelev AA; Kuznetsov MP; Rozhkov AE
    Klin Med (Mosk); 1980 Apr; 58(4):83-7. PubMed ID: 7382373
    [No Abstract]   [Full Text] [Related]  

  • 16. [First experience with a combined chemotherapeutic agent in pyelonephritis].
    Davogg S; Watschinger B
    Wien Klin Wochenschr; 1970 May; 82(18):337-9. PubMed ID: 4930125
    [No Abstract]   [Full Text] [Related]  

  • 17. [Antibacterial effect of cephalexin monohydrate in urinary tract infections].
    Torres J; Guevara I; Hernandez H
    Prensa Med Mex; 1970; ():65-8. PubMed ID: 4931120
    [No Abstract]   [Full Text] [Related]  

  • 18. [Vibramycin in the treatment of chronic pyelonephritis].
    Czekalski S; Krzymański M; Zych J; Wojtczak A
    Pol Tyg Lek; 1972 Sep; 27(39):1523-5. PubMed ID: 4563739
    [No Abstract]   [Full Text] [Related]  

  • 19. Successful treatment of ctx-m ESBL producing Escherichia coli relapsing pyelonephritis with long term pivmecillinam.
    Nicolle LE; Mulvey MR
    Scand J Infect Dis; 2007; 39(8):748-9. PubMed ID: 17654359
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Clinical evaluation of nalidixic acid (nevigramon) in the treatment of chronic pyelonephritis].
    Chodorowski Z; Hebanowski M
    Pol Tyg Lek; 1973 Aug; 28(33):1282-4. PubMed ID: 4742302
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.